Emergence of Omicron sub-variant BA.2: Is it a matter of concern amid the COVID-19 pandemic?
- 20 February 2022
- journal article
- letter
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 99, 106581
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Covid-19: What do we know about omicron sublineages?BMJ, 2022
- Covid-19: Past infection may not protect against future variants, researcher warns2022
- Omicron sub-lineage BA.2 may have “substantial growth advantage,” UKHSA reportsBMJ, 2022
- Emergence of Omicron third lineage BA.3 and its importanceJournal of Medical Virology, 2022
- Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review articleInternational Journal of Surgery, 2022
- Adjudicating the logistics of COVID-19 vaccine boosters from a global perspectiveHuman Vaccines & Immunotherapeutics, 2022
- Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South AfricaJournal of Medical Virology, 2021
- Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learntInternational Journal of Surgery, 2021
- Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of actionInternational Journal of Surgery, 2021